Sensitivity of Haemophilus influenzae isolates in Spain to 17 oral antibiotics;Sensibilidad de Haemophilus influenzae aislados en España a 17 antimicrobianos de administración oral

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 3, 2003, Pages 131-136

  Aracil, Belén ^a   Gómez Garcés, José Luis ^a   Alós, Juan Ignacio ^a  

^a HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

Antimicrobial susceptibility; Haemophilus influenzae; National surveillance study

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFTIBUTEN; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; LORACARBEF; NALIDIXIC ACID; RIFAMPICIN; TETRACYCLINE; TROVAFLOXACIN;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DRUG SURVEILLANCE PROGRAM; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SPAIN;

EID: 0037350034     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0213-005x(03)72901-2     Document Type: Article

References (22)

1. Moxon ER. Haemophilus influenzae. En: Mandell GL, Douglas, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone, 1995; p. 2039-45.
2. Campos JM. Haemophilus. En: Murray JM, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 6th ed. Washington: ASM Press, 1995; p. 556-65.
3. Tomeh M, Starr SE, McGovan JE, Terry PM, Nahmias AJ. Ampicillin-resistant Haemophilus influenzae type b infection. JAMA 1974;229:295-7.
4. Gunn BA, Woodall JB, Jones JF, Thornsberry C. Ampicillin-resistant Haemophilus influenzae. Lancet 1974;2:845.
5. Khan W, Starr SE, Rodríguez W, Controni G, Sa AK. Haemophilus influenzae type b resistant to ampicillin: A report of two cases. JAMA 1974;229:298-301.
6. Perea EJ, García MC, Clavijo MJ, Piédrola G, Campos J, García-Rodríguez JA, et al. Resistencias en Haemophilus influenzae en Espańa. Segundo estudio (1990). Enferm Infec Microbiol Clin 1993;11:19-28.
7. Doern GV, Brueggemann AB, Pierce G, Holley HP Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavunate: Results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997;41:292-7.
8. Doern GV, Jones RN, Pfaller MA, Kugler K, and The SENTRY Participants Group. Haemophilus influenzae and Moraxella catarrhalis from patients with comunnity-acquiered respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United Stated and Canada, 1997). Antimicrob Agents Chemother 1999;43:385-9.
9. Thornsberry C, Ogilvie PT, Holley HP Jr, Sahm DF. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrob Agents Chemother 1999;43:2612-23.
10. Marco F, García de Lomas J, García-Rey C, Bouza E, Aguilar L, FernándezMazarrasa C. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob Agents Chemother 2001;45:3226-8.
11. Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, et al. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001;45:1693-9.
12. Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, et al. Protein diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002;46:2208-18.
13. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically (Fifth Edition M7-A4: Supplemental tables M100-S10. NCCLS 2000; Villanova, PA.
14. Rubin LG, Yolken RH, Medeiros AA, Moxon ER. Ampicillin treatment failure of apparently β-lactamase-negative Haemophilus influenzae type b meningitis due to novel β-lactamase. Lancet 1981;2:1008-10.
15. Scriver SR, Walmsley SL, Kau CL, Hoban DJ, Brunton J, McGeer A, et al, and Canadian Haemophilus Study Grou, Low DE. Determination of antimicrobial susceptibilitis of Canadian isolates of Haemophilus influenzae and characterizacion of their β-lactamases. Antimicrob Agents Chemother 1994;38:1678-80.
16. Machka K, Braveny I, Dabernet H, Dornbush K, Van Dyck E, Kayser FH, et al. Distribution and resistance patterns of Haemophilus influenzae: A European cooperative study. Europ J Clin Microbiol Infect Dis 1988;7:14-24.
17. Kayser FH, Morenzoni G, Santanam P. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Europ J Clin Microbiol Infect Dis 1990;9:810-7.
18. Rittenhouse SF, Miller LA, Kaplan RL, Mosely GH, Poupard JA. A survey of β-lactamase-producing Haemophilus influenzae. Diagnost Microbiol Infect Dis 1995;21:223-5.
19. García de Lomas J, Grupo Español para Vigilancia de Patógenos Respiratorios. Situación epidemiológica actual y resistencia de los patógenos respiratorios en España. Med Clin (Barc) 1998;110(Supl 1):S44-S51.
20. Black SB, Shinefield HR, The Kaiser Permanente Vaccine Study Group. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large HMO population: Extended follow-up and impact on Haemophilus influenzae disease epidemiology. Ped Infect Dis J 1992;11:610-3.
21. Karlowsky JA, Verma G, Zhanel GG, Hoban DJ. Presence of ROB-1 β-lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influenzae. J Antimicrob Chemother 2000;45:871-5.
22. Okamoto S, Hamana Y, Inove M, Mitsuhashi S.In vitro and in vivo antibacterial activity of T-2588, a new oral cephalosporin, compared with those of other oral β-lactam antibiotics. Antimicrob Agents Chemother 1987;3:1111-6.